Use of polylysine dendrimers in the prevention and management of acne-prone skin and acneic skin
US12083157B2 · kind B2 · utility
0Cited by
3References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 21, 2020 |
| Grant date | Sep 10, 2024 |
| Priority date | — |
| Expiry date | Jul 6, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/544
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating acne vulgaris by administering a polylysine dendrimer or a salt thereof. Methods for the management of blemish- or acne-prone skin are also described. The polylysine dendrimer is used as an active for restoring or rebalancing skin microbiota. The polylysine dendrimer is also used as an active agent for improving or restoring the aspect and the feel of the skin to be treated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.